P021 ADALIMUMAB TROUGH SERUM LEVELS AND CLINICAL RESPONSE IN A SINGLE-CENTER COHORT OF INFLAMMATORY BOWEL DISEASE PATIENTS: CAN TROUGH SERUM LEVELS SERVE AS A PREDICTOR FOR FUTURE LOSS OF RESPONSE?
K. Karmiris, G. Paintaud, D. Degenne, M. Ferrante, A. Duveau, M. Noman, G. Van Assche, S. Vermeire, P. RutgeertsVolume:
2
Year:
2008
Language:
english
DOI:
10.1016/s1873-9954(08)70032-6
File:
PDF, 76 KB
english, 2008